JP4031254B2 - Drug container and assembled drug container - Google Patents

Description

[0001]
BACKGROUND OF THE INVENTION
The present invention relates to a drug container and an assembled drug container that contain a room-temperature volatile drug such as a pest control agent, a fragrance, and a deodorant.
[0002]
[Prior art]
Conventionally, as a medicine container, a medicine holder such as paper or non-woven fabric impregnated with a volatile medicine (active ingredient such as vapor slin) is contained in a container, and further individually wrapped with a barrier packaging material. There is.
[0003]
On the other hand, a drug container is also used in which a drug is accommodated in a container having an opening for volatilization of the drug and the opening for volatilization of the drug is closed with a sealing material such as a film.
[0004]
[Problems to be solved by the invention]
The drug container in which the drug holder is accommodated in the container and wrapped with the packaging material is opened before the packaging material is opened (before the start of use), and between the drug holder and the container or between the container and the packaging material. The drug volatilizes from the drug holder in the gap, and the amount of the drug that acts effectively after opening (when used) tends to decrease. Moreover, it is difficult to obtain a stable drug volatilization effect over a long period of time. For example, when a predetermined time elapses after starting use, the drug volatilization effect may be weakened. In addition, there is a cost for individually packaging with packaging materials, and in particular, when storing a plurality of drug holders impregnated with different drugs in a container, it is necessary to pack each drug holder, which increases the packaging cost. End up with.
[0005]
On the other hand, a drug container in which an opening for volatilization of a drug is closed with a sealing material requires an operation of attaching the sealing material at the time of manufacture, which hinders cost reduction. In addition, even with such a drug container, it is difficult to obtain a stable drug volatilization effect over a long period of time, and the drug volatilization effect may be weakened after a predetermined time has elapsed since the start of use.
[0006]
Furthermore, with conventional drug containers, the user has not been able to adjust the amount of drug volatilization. For example, the preference of the intensity of fragrance varies depending on the user, but in the conventional drug container containing the fragrance, the user cannot adjust the intensity of the fragrance. Moreover, when it was not necessary to volatilize a chemical | medical agent, volatilization could not be stopped.
The present invention has been made in view of the above circumstances, and an object thereof is to provide a drug container that can be manufactured at low cost, can obtain a stable drug volatilization effect over a long period of time, and can adjust the volatilization amount of the drug. There is.
[0007]
[Means for Solving the Problems]
The object of the present invention is achieved by the following configurations.
(1) An assembled drug container in which drug containers of the same shape containing normal temperature volatile drugs are stacked in multiple stages, each drug container being erected on a plate-like base and one surface of the base A container side wall forming the drug container inside, a partition wall partitioning the container into a plurality of chambers, and the other side of the base standing up and stacked on the inside has a mating side wall the housing part side walls of the medicine container is inserted and fitted, and the other surface of the base, the tip of the housing side walls and the partition wall of the other medicine container stacked is A recessed portion to be fitted is formed, and the height of the accommodating portion side wall and the partition wall is set to be higher than the height of the fitted side wall by the amount fitted into the recessed portion. The top of the container side wall and the partition wall of the drug container other than A drug container that fits into the concave portion of the container and in which an outer peripheral surface of the side wall of the housing portion is in close contact with an inner peripheral surface of the fitting side wall of the upper drug container.
[0008]
According to the said structure, by manufacturing the medicine container of one kind of shape, these medicine containers can be assembled and a medicine can be stored in the storage part of each medicine container. Therefore, since the mold cost can be reduced, the drug container and the assembled drug container can be manufactured at low cost. In addition, by providing the medicine container with a function of closing the container of the other medicine container, it is possible to reduce or eliminate the conventionally required packaging material and sealing material, thereby reducing the cost.
In addition, for example, only the container part of the uppermost drug container of the stacked drug containers is opened and the drug is volatilized therefrom, and when the drug volatilization effect is weakened, the container part of the next drug container is opened. Then, it is possible to use the medicine in such a manner that the medicine is volatilized therefrom, whereby a stable medicine volatilization effect can be obtained over a long period of time. Also, volatilization can be stopped by combining the drug containers again.
In addition, it is possible to use the medicine containers stacked in multiple stages and volatilize the same kind or different kind of medicine from each of the separated medicine containers at the same time. It can be carried out.
[0009]
Examples of the drug include those containing an insecticidal component, insect repellent component, repellent component, those containing an aromatic component, those containing a component having antibacterial activity, and those containing a component having a deodorizing action. You may make a chemical | medical agent hold | maintain on chemical | medical agent holders, such as paper, a nonwoven fabric, and resin. As the drug holder, gel, gel, sol, jelly, paste, granular, etc. can be used.
The drug container can be made of a material that does not allow permeation or adsorption of volatile drug at room temperature. The material is polyester, polyamide, vinyl chloride, polyvinylidene chloride, copolymer of vinyl chloride and vinylidene chloride, acrylonitrile composition 60% or more selected from copolymer, polyacetal, polycarbonate, polysulfone, polyphenylene ether, methylpentene polymer, fluorine resin, ethylene / vinyl chloride copolymer, chlorinated polyvinyl chloride, chlorinated polyethylene, chlorinated polypropylene, and vinylon One kind or two or more kinds of resins may be mentioned. Natural synthetic rubber, wood, or metal may be used as the material of the drug container. By configuring the drug container with these materials, it is possible to eliminate the need for packaging with a separate packaging material.
[0010]
DETAILED DESCRIPTION OF THE INVENTION
Hereinafter, embodiments of the present invention will be described with reference to the drawings. FIG. 1 shows an assembled drug container (indoor fragrance container) 20 according to the first embodiment. The assembled medicine container 20 has a configuration in which a plurality of (here, five) medicine containers 10 having the same shape are stacked, and each medicine container 10 contains a medicine (here, a medicine holder 15). The assembly drug container 20 may be packaged by a single packaging material such as an aluminum pack.
Each medicine container 10 can be obtained by resin molding.
[0011]
Each drug container 10 includes a plate-like base portion 11, a cylindrical side wall 12 erected on one surface (upper surface in the drawing) of the base portion 11, and a cylindrical shape erected on the other surface of the base portion 11. It has a fitting side wall 13. The space inside the side wall 12 serves as the accommodating portion 12a.
Here, the side wall 12 and the fitting side wall 13 extend in the same direction so that there is no undercut when the drug container 10 is molded with resin.
[0012]
In the present embodiment, the outer diameter of the side wall 12 is substantially equal to the inner diameter of the fitting side wall 13. In the figure, a second-stage drug container 10 is combined under the uppermost drug container 10, a third-stage drug container 10 is placed under the second-stage drug container 10, a fourth-stage, a fifth-stage, and so on. The drug containers 10 are sequentially combined. The drug container 10 other than the uppermost drug container has a side wall 12 inserted and fitted into a fitting side wall 13 provided in a drug container one level above the drug container. Thus, the container 12a of the drug container 10 other than the uppermost drug container is sealed by the base 11 of the drug container on the first level in a state where the drug holder 15 is stored. In this embodiment, the distal end surface of the side wall 12 of the drug container 10 is in close contact with the lower surface of the base 11 of the drug container 10 on the first level, and the outer peripheral surface of the side wall 12 is fitted to the drug container 10 on the first level. Although it is closely attached to the inner peripheral surface of the side wall 13, any one of them may be separated.
Here, it has been shown that the medicine holder 15 is not housed in the container 12a of the uppermost drug container 10, but the drug holder 15 is also housed in the container 12a of the uppermost drug container 10. May be.
[0013]
In FIG. 2, the 1st example of the usage pattern of the assembly chemical | medical agent container 20 is shown. As shown in FIG. 2, the assembled medicine container 20 is placed on the indoor installation surface S, and the uppermost medicine container 10 is removed from the second-stage medicine container 10. Then, the medicine is volatilized from the medicine holding body 15 housed in the housing portion 12a of the second-stage medicine container 10. When the drug volatilization effect from the second-stage drug holder 15 is weakened, the second-stage drug container 10 is removed from the third-stage drug container 10 and placed in the accommodating portion 12a of the third-stage drug container 10. The medicine is volatilized from the contained medicine holder 15. Thus, each time the drug volatilization effect becomes weak, the drug container at the uppermost stage at that time is sequentially removed from the drug container at the next stage, whereby a stable and constant drug volatilization effect can be obtained over a long period of time.
For example, when it is not necessary to volatilize the medicine, for example, when the user goes out, the medicine container 10 once removed is recombined, and the container 12a of the lower medicine container 10 is closed to stop the volatilization of the medicine. It can also be made.
The fitting side wall 13 of the lowermost drug container 10 functions as a leg portion that stably supports the assembled drug container 20 on the installation surface S.
[0014]
In FIG. 3, the 2nd example of the usage form of the assembly chemical | medical agent container 20 is shown. As shown in FIG. 3, the lowermost drug container 10 of the assembled drug container 20 can be removed, and the removed drug container 10 can be placed on a predetermined installation surface. The remaining part of the assembled drug container 20 from which the lowermost drug container 10 has been removed can be put in the packaging material again.
[0015]
FIG. 4 shows a third example of the usage pattern of the assembled drug container 20. As shown in FIG. 4, the assembled medicine container 20 can be separated into two or more parts, and the medicine can be volatilized simultaneously from each of the separated medicine containers 10. In this way, the amount of chemical volatilization can be increased according to user preferences.
It is also possible to place each of the separated drug containers 10 at a distant position, for example, in a different room.
[0016]
FIG. 5 shows an assembled drug container 40 according to the second embodiment. The assembled drug container 20 has a configuration in which a plurality of (here, two) drug containers 30 having the same shape are stacked.
Each drug container 30 includes a plate-like base 31, a cylindrical side wall 32 erected on one surface of the base 31 (upper surface in the figure), and a side wall 32 erected on one surface of the base 31. It has a partition wall 34 that partitions the inner housing portion 32 into a plurality of chambers 32 a and 32 b, and a cylindrical fitting side wall 33 that is erected on the other surface of the base portion 31. The height of the partition wall 34 can be made equal to the height of the side wall 32.
[0017]
Drug holding bodies 35a and 35b impregnated with different drugs can be stored in the plurality of chambers 32a and 32b of the storage portion 32 of the lower drug container 30.
The upper openings of the plurality of chambers 32 a and 32 b of the lower drug container 30 are sealed by the lower surface of the base 31 of the upper drug container 30 stacked on the lower drug container 30.
In use, by removing the upper drug container 30, different drugs can be volatilized simultaneously from the lower drug container 30. For example, one medicine holder 35a can be impregnated with a lemon flavor, and the other medicine holder 35b can be impregnated with a lime flavor.
In addition, it is possible to impregnate one medicine holding body 35a with a deodorizing agent and impregnate the other medicine holding body 35b with an insect repellent.
[0018]
FIG. 6 shows an assembly drug container 60 according to the third embodiment. The assembled medicine container 60 is configured by stacking a plurality of (here, two) medicine containers 50 having the same shape.
Each drug container 50 includes a plate-like base 51, a cylindrical side wall 52 erected on one surface of the base 51 (upper surface in the drawing), and a side wall 52 erected on one surface of the base 51. It has a partition wall 54 that partitions the inner accommodating portion 52 into a plurality of chambers 52 a and 52 b, and a cylindrical fitting side wall 53 erected on the other surface of the base portion 51. The height of the partition wall 54 can be made equal to the height of the side wall 52.
[0019]
In the present embodiment, the height of the side wall 52 and the partition wall 54 erected on one surface of the base 51 is higher than the height of the fitting side wall 53 erected on the other surface of the base 51. . On the other side of the base 51, recessed portions 51a and 51b into which the distal end of the side wall 52 and the distal end of the partition wall 54 of the lower drug container 50 are fitted are provided at predetermined positions inside the fitting side wall 53. The outer peripheral surface of the side wall 52 of the drug container 50 is in close contact with the inner peripheral surface of the fitting side wall 53 of the drug container 10 on the first level.
According to this embodiment, a high sealing effect is obtained.
[0020]
In addition, this invention is not limited to embodiment mentioned above, A suitable deformation | transformation, improvement, etc. are possible.
The form of the medicine container is not limited as long as it can be stacked in multiple stages, and may be stacked in the horizontal direction, not limited to the vertical direction.
The side wall of one drug container and the fitting side wall of another drug container may be screwed together.
[0021]
【The invention's effect】
As described above, according to the present invention, it is possible to provide a drug container and an assembled drug container that can be manufactured at low cost, can obtain a stable drug volatilization effect over a long period of time, and can adjust the drug volatilization amount.
[Brief description of the drawings]
FIG. 1 is a longitudinal sectional view of an assembly drug container according to a first embodiment of the present invention.
FIG. 2 is a diagram illustrating a usage pattern of the first embodiment.
FIG. 3 is a diagram illustrating a usage pattern of the first embodiment.
FIG. 4 is a diagram illustrating a usage pattern of the first embodiment.
FIG. 5 is a longitudinal sectional view of an assembled drug container according to the second embodiment.
FIG. 6 is a longitudinal sectional view of an assembled drug container according to a third embodiment.
[Explanation of symbols]
10, 30, 50 Drug container 11, 31, 51 Base 12, 32, 52 Side wall 13, 33, 53 Fitting side wall 15, 35a, 35b Drug holder (drug)
20, 40, 60 Assembly drug container 34, 54 Partition wall

Claims (1)

An assembled drug container in which drug containers of the same shape containing normal temperature volatile drugs are stacked in multiple stages,
Each medicine container has a plate-like base, a container side wall that stands on one surface of the base and forms the medicine container inside, and a partition wall that partitions the container into a plurality of chambers And a fitting side wall which is erected on the other surface of the base portion and into which the accommodating portion side wall of another stacked medicine container is inserted and fitted,
The other surface of the base is formed with a recess into which the distal ends of the container side wall and the partition wall of other stacked drug containers are fitted,
The height of the accommodating portion side wall and the partition wall is set higher than the height of the fitting side wall by the amount that fits into the recess,
When the drug containers are stacked, the side walls of the container other than the uppermost container and the front ends of the partition walls are fitted into the recesses of the drug container on the upper level, and the outer peripheral surface of the side wall of the container is the uppermost level. A drug container in close contact with the inner peripheral surface of the fitting side wall of the drug container.

Images